Bill
Bill > SB00439
CT SB00439
CT SB00439An Act Requiring Medicaid Coverage For Bone Marrow And Stem Cell Transplants And Fda-approved Gene Therapies To Treat Sickle Cell Disease.
summary
Introduced
01/10/2025
01/10/2025
In Committee
01/10/2025
01/10/2025
Crossed Over
Passed
Dead
06/04/2025
06/04/2025
Introduced Session
2025 General Assembly
Bill Summary
To provide equitable access to life-changing medical advancements to treat sickle cell disease, ameliorate suffering and reduce long-term health care costs.
AI Summary
This bill requires Connecticut's Medicaid program to cover bone marrow and stem cell transplants, as well as gene therapies that have been approved by the Food and Drug Administration (FDA) specifically for treating sickle cell disease. Sickle cell disease is a genetic blood disorder that causes red blood cells to become misshapen and break down, leading to serious health complications. By mandating coverage for these advanced medical treatments, the bill aims to improve access to potentially life-changing therapies for patients with this condition. The legislation is designed to provide more equitable healthcare options for individuals with sickle cell disease, potentially reducing long-term medical costs by offering treatments that could ameliorate the suffering associated with the disease and potentially provide more effective management of the condition.
Committee Categories
Health and Social Services
Sponsors (1)
Last Action
Referred to Joint Committee on Human Services (on 01/10/2025)
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://www.cga.ct.gov/asp/cgabillstatus/cgabillstatus.asp?selBillType=Bill&bill_num=SB00439&which_year=2025 |
| BillText | https://www.cga.ct.gov/2025/TOB/S/PDF/2025SB-00439-R00-SB.PDF |
Loading...